Innovation Inc. Logo

Innovation Inc.

Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.

3970 | T

Overview

Corporate Details

ISIN(s):
JP3147900009
LEI:
Country:
Japan
Address:
渋谷区渋谷3‐10‐13TOKYUREIT渋谷Rビル3F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Innovation Inc. is a multifaceted B2B services company that supports corporate growth through digital transformation and financial solutions. The company operates several key business lines. Its Online Media division manages platforms like "IT Trend," a B2B product matching service, and "bizplay," a business video platform, to facilitate lead generation and marketing. The IT Solutions segment provides marketing automation tools such as "List Finder" and sales support cloud software like "Sales Doc." Additionally, its Financial Platform offers specialized M &A advisory and asset consulting services. The company also invests in emerging businesses through its corporate venture capital funds, fostering innovation in the startup ecosystem.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-25 07:06
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2025-06-24 07:41
Registration Form
確認書
Japanese 8.1 KB
2025-06-24 07:39
Governance Information
内部統制報告書-第25期(2024/04/01-2025/03/31)
Japanese 23.8 KB
2025-06-24 07:36
Registration Form
有価証券報告書-第25期(2024/04/01-2025/03/31)
Japanese 1.5 MB
2025-06-04 03:07
Capital/Financing Update
臨時報告書
Japanese 18.8 KB
2025-05-13 04:39
Regulatory News Service
臨時報告書
Japanese 20.6 KB
2025-01-24 04:06
Major Shareholding Notification
変更報告書
Japanese 42.0 KB
2025-01-21 08:20
M&A Activity
公開買付報告書
Japanese 63.4 KB
2025-01-21 08:10
Major Shareholding Notification
大量保有報告書
Japanese 41.2 KB
2025-01-21 08:07
Capital/Financing Update
臨時報告書
Japanese 20.7 KB
2025-01-21 08:06
M&A Activity
臨時報告書
Japanese 21.9 KB
2024-12-16 06:20
M&A Activity
公開買付届出書
Japanese 439.5 KB
2024-11-14 07:56
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-14 07:53
Interim Report
半期報告書-第25期(2024/04/01-2025/03/31)
Japanese 196.4 KB
2024-11-01 04:51
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.7 KB

Automate Your Workflow. Get a real-time feed of all Innovation Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Innovation Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Innovation Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.